Exact Stock Analysis


USD 47.05  2.32  4.70%   

The latest indifference towards the small price fluctuations of Exact Sciences Cor could raise concerns from retail investors as the firm is trading at a share price of 47.05 on 2,885,700 in volume. The company management teams did not add any value to Exact Sciences investors in July. However, most investors can still diversify their portfolios with Exact Sciences Cor to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.57. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Exact Sciences partners.
Continue to Investing Opportunities.
The Exact Sciences stock analysis report makes it easy to digest most publicly released information about Exact Sciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Exact Stock analysis module also helps to analyze the Exact Sciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Exact Stock Analysis Notes

About 94.0% of the company shares are held by institutions such as insurance companies. The book value of Exact Sciences was currently reported as 18.56. The company recorded a loss per share of 4.32. Exact Sciences Cor had not issued any dividends in recent years. Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people. To learn more about Exact Sciences Cor call Kevin Conroy at 608 284 5700 or check out https://www.exactsciences.com.

Exact Sciences Quarterly Cost of Revenue

144.6 Million

Exact Sciences Cor Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Exact Sciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Exact Sciences Cor or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Exact Sciences Cor has very high historical volatility over the last 90 days
Exact Sciences Cor has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 1.85 B. Net Loss for the year was (745.4 M) with profit before overhead, payroll, taxes, and interest of 1.31 B.
Exact Sciences Cor currently holds about 816.98 M in cash with (198.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.64.
Exact Sciences Cor has a frail financial position based on the latest SEC disclosures
Over 94.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.digitaljournal.com: Global Cancer Diagnostics Market Research Report Predictable To Exceed Market Income, Shares and Competitive Landscape 2028 - Digital Journal

Exact Sciences Cor Upcoming and Recent Events

Earnings reports are used by Exact Sciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Exact Sciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report15th of February 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End15th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Exact Largest EPS Surprises

Earnings surprises can significantly impact Exact Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Exact Sciences SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Exact Sciences prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Exact Sciences investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Exact Sciences Cor specific information freely available to individual and institutional investors to make a timely investment decision.
30th of June 2022
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
10th of June 2022
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
2nd of May 2022
Financial Statements and Exhibits. Other Events
26th of April 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
10th of March 2022
Unclassified Corporate Event
22nd of February 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
14th of February 2022
Unclassified Corporate Event
11th of February 2022
Unclassified Corporate Event

Exact Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Exact Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Exact Sciences Cor backward and forwards among themselves. Exact Sciences' institutional investor refers to the entity that pools money to purchase Exact Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Ark Investment Management LlcCommon Shares15 M745.7 M
Sumitomo Mitsui Trust Holdings IncCommon Shares5.8 M228.8 M
Nikko Asset Management Americas IncCommon Shares5.3 M199.9 M
Wolverine Asset Management LlcDebt119.1 M85.2 M
Frontier Capital Management Co Llc 1Common Shares528.8 K20.8 M
New York State Common Retirement FundCommon Shares518.5 K20.4 M
C Worldwide Group Holding ACommon Shares448.9 K17.7 M
Peregrine Capital Management LlcCommon Shares446 K17.6 M
Simplex Trading LlcCall Options181.2 K7.1 M
Note, although Exact Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Exact Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 8.43 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Exact Sciences's market, we take the total number of its shares issued and multiply it by Exact Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Exact Profitablity

Exact Sciences' profitability indicators refer to fundamental financial ratios that showcase Exact Sciences' ability to generate income relative to its revenue or operating costs. If, let's say, Exact Sciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Exact Sciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Exact Sciences' profitability requires more research than a typical breakdown of Exact Sciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (40.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (28.37) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.28.
Last ReportedProjected for 2022
Return on Investment(17.13) (18.48) 
Return on Average Assets(0.09) (0.1) 
Return on Average Equity(0.17) (0.18) 
Return on Invested Capital(0.23) (0.25) 
Return on Sales(0.47) (0.50) 

Management Efficiency

The entity has return on total asset (ROA) of (6.71) % which means that it has lost $6.71 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (21.58) %, meaning that it created substantial loss on money invested by shareholders. Exact Sciences management efficiency ratios could be used to measure how well exact sciences cor manages its routine affairs as well as how well it operates its assets and liabilities. As of 08/07/2022, Return on Investment is likely to drop to -18.48. In addition to that, Return on Average Assets is likely to drop to -0.1. Exact Sciences Total Assets are relatively stable at the moment as compared to the past year. Exact Sciences reported last year Total Assets of 6.68 Billion. As of 08/07/2022, Assets Non Current is likely to grow to about 5.7 B, while Revenue to Assets are likely to drop 0.21.
Last ReportedProjected for 2022
Book Value per Share 19.77  21.33 
Enterprise Value over EBIT(19.00) (20.50) 
Enterprise Value over EBITDA(25.13) (27.11) 
Price to Book Value 3.96  6.02 
Tangible Assets Book Value per Share 13.16  10.89 
Enterprise Value15.5 B16.7 B
Tangible Asset Value2.3 B2.4 B

Technical Drivers

As of the 7th of August, Exact Sciences shows the mean deviation of 3.9. Exact Sciences Cor technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Exact Sciences Cor, which can be compared to its rivals. Please confirm Exact Sciences Cor coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Exact Sciences Cor is priced favorably, providing market reflects its regular price of 47.05 per share. Given that Exact Sciences has jensen alpha of (0.13), we urge you to verify Exact Sciences Cor's prevailing market performance to make sure the company can sustain itself at a future point.

Exact Sciences Cor Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Exact Sciences Cor price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.

Exact Sciences Cor Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Exact Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Exact Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Exact Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Katherine Zanotti over a week ago via Macroaxis 
Exercise or conversion by Katherine Zanotti of 4608 shares of Exact Sciences subject to Rule 16b-3
Kevin Conroy over a month ago via Macroaxis 
Exact Sciences exotic insider transaction detected
Katherine Zanotti over a month ago via Macroaxis 
Exact Sciences exotic insider transaction detected
Coward D Scott over a month ago via Macroaxis 
Sale by Coward D Scott of 5815 shares of Exact Sciences
Pierre Jacquet over a month ago via Macroaxis 
Acquisition by Pierre Jacquet of 7243 shares of Exact Sciences subject to Rule 16b-3
James Doyle over a month ago via Macroaxis 
Exercise or conversion by James Doyle of 3000 shares of Exact Sciences subject to Rule 16b-3
James Doyle over three months ago via Macroaxis 
Exercise or conversion by James Doyle of 10000 shares of Exact Sciences subject to Rule 16b-3
Kevin Conroy over three months ago via Macroaxis 
Exercise or conversion by Kevin Conroy of 9312 shares of Exact Sciences subject to Rule 16b-3
Condella Sarah over three months ago via Macroaxis 
Exercise or conversion by Condella Sarah of 2356 shares of Exact Sciences subject to Rule 16b-3
Condella Sarah over three months ago via Macroaxis 
Acquisition by Condella Sarah of 15817 shares of Exact Sciences subject to Rule 16b-3
Condella Sarah over three months ago via Macroaxis 
Exercise or conversion by Condella Sarah of 10197 shares of Exact Sciences subject to Rule 16b-3
Condella Sarah over three months ago via Macroaxis 
Exercise or conversion by Condella Sarah of 2247 shares of Exact Sciences subject to Rule 16b-3

Exact Sciences Predictive Daily Indicators

Exact Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Exact Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Exact Sciences Forecast Models

Exact Sciences time-series forecasting models is one of many Exact Sciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Exact Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Exact Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Exact Sciences stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Exact shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Exact Sciences. By using and applying Exact Stock analysis, traders can create a robust methodology for identifying Exact entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(48.42) (52.24) 
EBITDA Margin(0.35) (0.38) 
Gross Margin 0.74  0.72 
Profit Margin(0.34) (0.36) 
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people.

Current Exact Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Exact analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Exact analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Exact Sciences Cor current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Exact analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Exact stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Exact Sciences Cor, talking to its executives and customers, or listening to Exact conference calls.
Exact Analyst Advice Details

Exact Stock Analysis Indicators

Exact Sciences Cor stock analysis indicators help investors evaluate how Exact Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Exact Sciences shares will generate the highest return on investment. By understating and applying Exact Sciences stock analysis, traders can identify Exact Sciences position entry and exit signals to maximize returns.
Quick Ratio2.13
Fifty Two Week Low35.34
Revenue Growth21.00%
Average Daily Volume Last 10 Day1.61M
Shares Short Prior Month10.94M
Average Daily Volume In Three Month2.15M
Shares Percent Shares Out6.10%
Gross Margins73.89%
Forward Price Earnings-15.56
Short Percent Of Float6.90%
Float Shares174.2M
Fifty Two Week High108.99
Fifty Day Average45.28
Enterprise Value To Ebitda-18.83
Two Hundred Day Average68.04
Enterprise Value To Revenue5.34
Continue to Investing Opportunities. Note that the Exact Sciences Cor information on this page should be used as a complementary analysis to other Exact Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Exact Stock analysis

When running Exact Sciences Cor price analysis, check to measure Exact Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exact Sciences is operating at the current time. Most of Exact Sciences' value examination focuses on studying past and present price action to predict the probability of Exact Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Exact Sciences' price. Additionally, you may evaluate how the addition of Exact Sciences to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Exact Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exact Sciences. If investors know Exact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exact Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
8.3 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Exact Sciences Cor is measured differently than its book value, which is the value of Exact that is recorded on the company's balance sheet. Investors also form their own opinion of Exact Sciences' value that differs from its market value or its book value, called intrinsic value, which is Exact Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exact Sciences' market value can be influenced by many factors that don't directly affect Exact Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exact Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Exact Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exact Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.